Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Ingrid Burvenich

Awards & Distinctions

19 Results

2007

Biodistribution and planar gamma camera imaging of I-123- and I-131-labeled F(ab ')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor

Ingrid BurvenichSteve SchoonooghePeter BlanckaertKlaus BacherLiesbet VervoortElisabeth CoeneNico MertensFilip De VosGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE AND BIOLOGY

IDENTIFICATION AND CHARACTERIZATION OF MONOCLONAL ANTIBODY 14C5 - A potential agent for radioimmunodetection and -therapy

Ingrid BurvenichG Slegers

2005

In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model

Ingrid BurvenichSteve SchoonoogheBart CornelissenPeter BlanckaertElisabeth CoeneClaude CuvelierNico MertensGuido Slegers

A1 Journal Article in CLINICAL CANCER RESEARCH

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of Tc-99m labelled epidermal growth factor

Bart CornelissenVeerle KersemansIngrid BurvenichRuth OltenfreiterJL VANDERHEYDENO BOERMANC VANDEWIELEGuido Slegers

A1 Journal Article in NUCLEAR MEDICINE COMMUNICATIONS

Synthesis, quality control and in vivo evaluation of [I-123] rhTIMP-2, a potential tumour-imaging agent

Ruth OltenfreiterIngrid BurvenichLudovicus StaelensA LEJEUNEF FRANKENNEJM FOIDARTGuido Slegers

A1 Journal Article in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

2004

123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction

Bart CornelissenKatrien RemautVeerle KersemansRuth OltenfreiterIngrid BurvenichGuido Slegers

123I-labelled monoclonal antibody 14C5 for SPECT tumour imaging: In vivo evaluation of athymic mice bearing a LoVo tumour

Ingrid BurvenichBart CornelissenPeter BlanckaertElisabeth CoeneClaude CuvelierGuido SlegersSteve SchoonoogheNico Mertens

Improved targeting with F(ab)2 fragments of monoclonal antibody 14C5 for imaging and therapy of metastatic disease

Ingrid BurvenichKaren JanssenPeter BlanckaertSteve SchoonoogheElisabeth CoeneClaude CuvelierNico MertensGuido Slegers

In vitro evaluatie van 14C5 monoklonaal antilichaamderivaten voor gebruik in radioimmunodiagnostiek en radioimmunotherapie

Ingrid BurvenichKAREN JANSSENPeter BlanckaertGuido Slegers

Internalization and cellular processing of radiolabeled monoclonal antibody 14C5

Ingrid BurvenichSteve SchoonoogheRuth OltenfreiterPeter BlanckaertE COENEClaude CuvelierN MERTENSGuido Slegers

New strategies in polypeptide and antibody synthesis: An overview

Nico MertensF DEVOSJannick LeoenEls Van DeynseAn WillemsSteve SchoonoogheIngrid BurvenichStefaan De KokerDominique VliegheJohan Grooten et al.

A1 Journal Article in CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Precursor synthesis, radiosynthesis and in vivo evaluation in mice of [I-123]-(4-fluorophenyl) {1-[2-(2-iodophenyl)ethyl]piperidin-4-yl}-methanone and -methanol, as potential SPECT tracers for the 5-HT2A-receptor

Peter BlanckaertM VandecapelleIngrid BurvenichLudovicus StaelensGuido Slegers

Radiolabeling, biodistribution, and dosimetry of I-123-mAb 14C5: A new mAb for radioimmunodetection of tumor growth and metastasis in vivo

CMM LAHORTEKlaus BacherIngrid BurvenichElisabeth CoeneClaude CuvelierC DE POTTERHubert ThierensChristophe Van De WieleRudi DierckxGuido Slegers

A1 Journal Article in JOURNAL OF NUCLEAR MEDICINE

Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent

Ruth OltenfreiterLudovicus StaelensIngrid BurvenichBart CornelissenF FrankenneJM FoidartGuido Slegers

Radiosynthesis and in vivo evaluation of a carboxylic MMP inhibitor as potential SPECT tumour imaging agent

Ruth OltenfreiterLudovicus StaelensIngrid BurvenichF FrankenneJM FoidartGuido Slegers

Synthese van de precursor, radiosynthese en in vivo evaluatie in muizen van [123I]-(4-fluorofenyl){1-[2-(4-iodofenyl)ethyl]piperidin-4-yl}methanon, als potentiële SPECT ligand voor de 5-HT2A-receptor

Peter BlanckaertIne PatouMarleen VandecapelleIngrid BurvenichGuido Slegers

Synthesis, radiosynthesis and preliminary in vivo evaluation of [123I]-(1-(5-iodo-2-methoxyphenethyl)piperidin-4-yl)(4-fluorophenyl)methanone as a potential SPECT tracer for visualizing the 5-HT2A-receptor

Peter BlanckaertIngrid BurvenichGuido Slegers

Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging

Peter BlanckaertMarleen VandecapelleLudovicus StaelensIngrid BurvenichRudi DierckxGuido Slegers

A1 Journal Article in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Targeting properties of radiolabelled monoclonal antibody 14c5 directed against a cell substrate adhesion molecule

Ingrid BurvenichSteve SchoonooghePeter BlanckaertElisabeth CoeneBart CornelissenClaude CuvelierNico MertensGuido Slegers